Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer - Concepedia

Concepedia

Publication | Open Access

Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer

DOI Full Paper Access

218

Citations

40

References

2009

Year

Evan Y. Yu, George Wilding, Edwin M. Posadas, Mitchell E. Gross, Stéphane Culine, Christophe Massard, Michael J. Morris, Gary R. Hudes, Fabio Calabrò, Shinta Cheng,

Clinical Cancer Research

Abstract

This study provides encouraging evidence of dasatinib activity in bone and reasonable tolerability in chemotherapy-naive patients with metastatic CRPC.

References

	Year	Citations

Page 1